C39H67N5O7
718 g/mol
Intermediario farmacéuticoPeligro
Monomethyl auristatin E
CAS474645-27-7
Categoría
Intermediario farmacéutico
Clase de Compuesto
Péptido
Uso Principal
Intermediario farmacéutico
Monomethyl auristatin E is a complex peptide-based compound used as a pharmaceutical intermediate in the manufacturing of antibody-drug conjugates. Its structure features multiple amide groups, an aromatic ring, and several chiral centers, contributing to its role as a key building block in targeted therapeutic development.
pharmaceutical intermediate for antibody-drug conjugate manufacturing
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 474645-27-7
Compuestos relacionados
FuerteEstructura similarSimilitud 0.87
L-Valinamide, N,N-dimethyl-L-valyl-N-((1S,2R)-4-((2S)-2-((1R,2R)-3-(((1R,2S)-2-hydro xy-1-methyl-
CAS160800-57-7
active pharmaceutical ingredient
SimilarEstructura similarSimilitud 0.78
MMAF
CAS745017-94-1
pharmaceutical intermediate
SimilarEstructura similarSimilitud 0.73
Mc-MMAE
CAS863971-24-8
antibody-drug conjugate payload
AplicaciónMismo uso
MC-Gly-Gly-Phe-Gly
CAS2413428-36-9
pharmaceutical intermediate for antibody-drug conjugate
AplicaciónMismo uso
N-Acetyl calicheamicin
CAS108212-76-6
pharmaceutical intermediate for antibody-drug conjugate
ReferenciaMisma categoría
Hydronopol
CAS4747-61-9
Pharmaceutical intermediate for pivonium bromide
ReferenciaMisma categoría
Tert-Butyl 3,4-dihydroxypiperidine-1-carboxylate
CAS475062-48-7
Pharmaceutical intermediate
ReferenciaMisma categoría
(5-Bromo-1-(tert-butoxycarbonyl)-1H-indol-2-yl)boronic acid
CAS475102-13-7
Pharmaceutical intermediate for synthesis
Referencia de Seguridad
Peligro
H300Fatal if swallowed
H330Fatal if inhaled
H302Harmful if swallowed
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
H340May cause genetic defects
H341Suspected of causing genetic defects
H360May damage fertility or the unborn child
H370Causes damage to organs
H372Causes damage to organs through prolonged or repeated exposure
H412Harmful to aquatic life with long lasting effects
Identificadores
Nombre IUPAC
(2S)-N-[(2S)-1-[[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-3-[[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl]-3-methoxy-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]-3-methyl-2-(methylamino)butanamide
InChIKey
DASWEROEPLKSEI-UIJRFTGLSA-N
SMILES
CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@@H](C)C(=O)N[C@H](C)[C@H](C2=CC=CC=C2)O)OC)OC)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC
Sinónimos (22)
- 4Q5
- MMAE
- MMAE peptide
- Monomethyl auristatin E
- Monomethyl auristatin E (GMP)
- [3H]-Vedotin